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Abstract
Purpose The NexGen Legacy Posterior Stabilised (LPS) prosthesis (Zimmer Biomet, Warsaw, IN, USA) has augmentable 
and non-augmentable tibial baseplate options. We have noted an anecdotal increase in the number of cases requiring early 
revision for aseptic loosening since adopting the non-augmentable option. The purpose of this study was to ascertain our 
rates of aseptic tibial loosening for the two implant types within five years of implantation and to investigate the causes for 
any difference observed.
Methods A database search was performed for all patients who underwent primary total knee arthroplasty (TKA) using the 
NexGen LPS between 2009 and 2015. Kaplan–Meier curves were plotted to assess for differences in revision rates between 
cohorts. We collected and compared data on gender, age, body mass index, component alignment and cement mantle quality 
as these were factors thought to affect the likelihood of aseptic loosening.
Results Two thousand one hundred seventy-two TKAs were included with five year follow-up. There were 759 augmenta-
ble knees of which 14 were revised and 1413 non-augmentable knees of which 48 were revised. The overall revision rate 
at five years was 1.84% in the augmentable cohort and 3.4% in the non-augmentable cohort. The revision rate for aseptic 
loosening was 0.26% in the augmentable group and 1.42% in the non-augmentable group (p = 0.0241).
Conclusions We have identified increased rates of aseptic loosening in non-augmentable components. This highlights the 
effect that minor implant changes can have on outcomes. We recommend that clinicians remain alert to implant changes and 
publish their own results when important trends are observed.
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Introduction
Total knee arthroplasty (TKA) remains the gold standard 
treatment for symptomatic arthritis of the knee and can sig-
nificantly improve quality of life for the majority of patients; 
however, there are undoubtedly still problems related to this 
procedure which remain unresolved [1]. Since the advent 
of TKA in the 1970s, revision rates have declined due to a 
combination of refinement of surgical technique, implant 
design, fixation methods and improved antisepsis. Despite 
the decrease in revision rates, the absolute numbers of revi-
sion procedures continue to increase due to the increasing 
number of primary procedures [2, 3]. The most common 
reason cited for revision knee arthroplasty is aseptic loosen-
ing of the components, particularly on the tibial side [2, 4].
The NexGen Legacy Posterior Stabilised (LPS) prosthe-
sis (Zimmer Biomet, Warsaw, IN, USA) was introduced to 
the market in 1997 and has been in use at our unit since 
2007 for all primary TKA. This prosthesis has augmenta-
ble and non-augmentable options (Fig. 1); the augmentable 
option features 4 polyethylene lugs on the underside of the 
baseplate which can be removed to allow for attachment 
of augments and a polyethylene screw at the tip of the keel 
which can be replaced by a range of stems should these be 
required (Fig. 2). The simpler non-augmentable version has 
neither of these options and is used for the uncomplicated 
primary TKA (Fig. 3). Baseplates are available with 3° and 
7° posterior slope stems. All of the tibial tray options are 
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manufactured using an alloy of Titanium Ti-6-Al-4 V and 
incorporate a dove-tail locking mechanism for the polyeth-
ylene insert [5]. In addition, the NexGen tibial baseplate 
can be supplied pre-coated with polymethyl methacrylate 
(PMMA) and a non-pre-coated option is available [6].
Recent joint registry data from the UK reports an all 
cause revision rate for the NexGen of 2.17% at five years 
[2]. This includes both cruciate retaining and posterior sta-
bilised designs and also a range of different tibial baseplates. 
Although registry data continues to become more sophisti-
cated over time, there is insufficient detail within the data 
to ascertain specific rates of aseptic loosening for different 
implants within a family of implants at the current time.
Until early 2011, our institution used a 7° augmentable 
version of the tibial baseplate in all of our primary TKAs 
in order to keep a consistent inventory and reduce variation. 
In early 2011, this baseplate was gradually phased out in 
Fig. 1  Clinical photograph of an augmentable baseplate (left) and a 
non-augmentable baseplate (right)
Fig. 2  Anteroposterior (AP) 
and lateral radiographs of an 
augmentable prosthesis. This 
component is identifiable by 
the presence of a radiolucent 
polyethylene peg at the tip of 
the keel on the tibial baseplate
Fig. 3  Anteroposterior (AP) and 
lateral radiographs of a non-
augmentable prosthesis. Note 
the absence of the radiolucent 




favour of a lower cost 7° non-augmentable option. At our 
institution, we have noted an anecdotal increase in the num-
ber of cases requiring early revision for aseptic loosening, 
particularly on the tibial side of the implant. The purpose 
of this study was to ascertain our observed rates of aseptic 
tibial loosening for the two implant types within five years 
of implantation and to investigate the causes for any differ-
ence observed. The hypothesis of this study was that there 
was an increased rate of aseptic tibial loosening in the non-
augmentable component compared to the augmentable tibial 
component as a result of minor differences in the baseplate 
design.
Materials and methods
A retrospective search of a prospectively collated Bluespier® 
(Bluespier International Ltd, Worcestershire, UK) arthro-
plasty database was performed for all primary total knee 
arthroplasties (TKAs) performed between 05/01/2009 and 
31/03/2015 in our institution with a minimum of five year 
follow-up. Our regional research and ethics committee were 
consulted prior to the study but formal ethical approval was 
not deemed necessary given that it included only a retro-
spective case note and radiograph review. The number of 
revision procedures was determined for this cohort during 
the five year period following implantation and the reason 
for revision was noted. The case notes for each patient who 
underwent revision were reviewed to ensure that the coded 
reason for revision was correct. The Musculoskeletal Infec-
tion Society (MSIS) criteria was used to determine whether 
infection was the cause for revision [7]. Patients were 
classed as having aseptic loosening if they had symptoms 
including pain, instability or swelling; had radiographic evi-
dence of loosening; and did not meet the MSIS criteria for 
infection. Data was collected to indicate the date of revision 
surgery or date of mortality, age at time of surgery, date 
of original surgery and body mass index (BMI) for each 
patient.
We included all patients who underwent primary TKA 
using the NexGen LPS-fixed bearing prosthesis. All of 
the implants were posterior stabilised and were cemented 
without stems or augments. All of the augmentable tibial 
components had a PMMA pre-coating. The non-augmenta-
ble tibial components had no PMMA pre-coating. Pala-
cos® R&G (Heraeus Medical, Hanau, Germany) cement 
was used until January 2012 until it was phased out over a 
two month period in order to reduce costs to Refobacin® 
(Zimmer Biomet, Warsaw, IN, USA). All procedures were 
performed by, or under the supervision of, one of the nine 
consultant orthopaedic surgeons within our institution. 
Over the study period, all surgeons that contributed to this 
study were high-volume specialists with an interest in knee 
arthroplasty. Technique for implantation was undertaken 
as per the operative technique recommended by the manu-
facturer although there were likely to be subtle differences 
in techniques utilised by each surgeon.
Post-operative radiographs for the included patients 
were reviewed to confirm each patient as having an aug-
mentable baseplate (7° fluted stem) or a non-augmentable 
baseplate (7° fluted stem). An assessment of post-operative 
alignment and cement mantle quality was performed for all 
patients who had a non-augmentable baseplate and under-
went revision for aseptic loosening. Radiographic views 
were performed in a standardised fashion by our radiol-
ogy department but long-leg radiographs were not avail-
able. This radiographic assessment was carried out using 
a standardised technique described by Hampton et al. [8]. 
Coronal alignment of the femoral and tibial components 
was measured on the anteroposterior radiograph and sag-
ittal tibial slope was measured on the lateral radiograph. 
The technique for cement mantle assessment is described 
in full within the original paper by Hampton et al. and 
involves counting the number of zones in which there 
is less than 2 mm of cement-bone penetration, counting 
radiolucent lines (RLL) and calculating the RLL as a per-
centage of the surface area available. To facilitate inter-
pretation of these results, we performed the same analysis 
on a control group of non-augmentable knees which did 
not go on to require revision and a control group of aug-
mentable knees which did not go on to require revision. 
The three control groups were selected from the database 
by searching for patients who were matched for age, BMI 
and gender as these factors could have an impact on revi-
sion rates. For completeness, we also assessed the cement 
mantle and alignment of the patients who had augmentable 
baseplates and underwent revision for aseptic loosening 
although this was a very small group (n = 2).
Statistical analysis was performed by an independent 
researcher using Graphpad Prism version 6. After sorting 
the primary TKAs into augmentable and non-augmentable 
cohorts, Kaplan–Meier curves were plotted to assess for 
differences in all revision rates and aseptic revision rates 
in both cohorts. Each cohort was also assessed to com-
pare demographics which could potentially affect rates of 
aseptic loosening. Shapiro–Wilk test was used to deter-
mine normality of data and before parametric and non-
parametric data was analysed using unpaired t tests and 
Mann–Whitney U tests, respectively. For comparisons 
containing more than two groups, parametric and non-
parametric data was analysed using Fisher’s LSD, one-way 
ANOVA or Kruskal–Wallis ANOVA with Dunn’s post-
test, respectively. Results were deemed significant with a 




Overall, 2172 TKAs were performed in the study period 
with 759 augmentable tibial components inserted between 
05/01/2009 and 01/2011 and 1413 non-augmentable tibial 
components between 01/2011 and 31/03/2015. During this 
5-year follow-up, there were 14 revisions in the augmentable 
group and 48 revisions within the non-augmentable group 
(Table 1).
There was no difference in BMI or age between either 
tibial implant group (Table 2) although some data for BMI 
was missing (augmentable cohort, 445/759; non-augmenta-
ble cohort, 769/1413). BMI and age were both recorded at 
the time of primary surgery. Due to the low patient num-
bers, it is difficult to draw conclusive comparisons between 
augmentable and non-augmentable revisions; however, 
BMI alone does not appear to account for the differences 
in aseptic revisions observed. Furthermore, it appears non-
augmentable aseptic loosening occurs in older patients com-
pared to augmentable loosening although this does not reach 
statistical significance (p = 0.051).
The overall all cause revision rate at five years was 1.84% 
in the augmentable cohort and 3.4% in the non-augmentable 
cohort. At this same time point, the revision rate for aseptic 
loosening was 0.26% in the augmentable group and 1.42% 
in the non-augmentable group. The difference in overall 
revision rate for the two components was not statistically 
significant when analysed using the Kaplan–Meier analy-
sis (Fig. 4). However, there was a significant difference 
(p = 0.0241) in implant failure due to aseptic tibial loosening 
requiring revision between the two cohorts (Fig. 5). The haz-
ard ratio (and confidence intervals) between non-augmenta-
ble and augmentable implant is 2.9 (1.1 to 7.5) suggesting 
that aseptic loosening requiring revision is statistically more 
likely in the non-augmentable implant cohort than the aug-
mentable cohort.
When assessing post-operative alignment of the non-aug-
mentable group which went on to require revision, there was 
no significant difference in coronal alignment of the femo-
ral or tibial components when compared to the two control 
groups. There was however a significant difference in the 
posterior slope between the aseptic loosening group (5.6°) 
Table 1  Frequency of indications and percentage of revision surgery 
following use of augmentable or non-augmentable implants







Aseptic loosening 2/0.26% 20/1.42%
Malalignment 2/0.26% 1/0.07%
Table 2  Age and body mass 
index for all augmentable and 
non-augmentable implant 
patients and revisions indicated 
by aseptic loosening
BMI Age
Mean (range) n P value Mean (range) n P value
Augmentable group 33.0 (17–56) 445 0.058 67.9 (35–89) 759 0.116
Non-augmentable group 32.3 (18–54) 769 68.1 (21–92) 1413
Augmentable aseptic loosening revisions 40.5 (36–45) 2 0.538 55.5 (55–56) 2 0.051
Non-augmentable aseptic loosening revisions 32.4 (23–41) 20 66.3 (56–79) 20
Fig. 4  Kaplan–Meier analysis 
of implant survivorship for 
5 years for all cause revisions 
in the augmentable and non-
augmentable implant cohorts 
(p = 0.0562)




































and the non-augmentable control group (3.2°) (p = 0.02) and 
the augmentable control group (3.4°) (p = 0.03) (Table 3).
The cement mantle was assessed (Table  3) and an 
increased number of RLL were found in the non-aug-
mentable aseptic loosening group (1.9) compared to the 
non-augmentable control group (0.8) (p =  < 0.05) and 
the augmentable control group (0.3) (p =  < 0.001). We 
also found a higher proportion of RLL as a percentage 
of the total surface area available in the non-augmenta-
ble aseptic loosening group (19.2%) compared to the 
non-augmentable control group (9.9%) (p =  < 0.05) and 
the augmentable control group (6.6%) (p =  < 0.01). There 
was no significant difference between any of the groups in 
terms of cement penetration and there was no significant 
difference between any of the measurements of alignment 
or cementation when comparing the two control groups. 
We have not performed statistical analysis on the align-
ment or cement mantle in the augmentable group asep-
tic loosening group because the patient numbers were 
so small (n = 2), anecdotally, though one of these knees 
showed an excellent cement mantle and one had several 
radiolucent lines.
Fig. 5  Kaplan–Meier analysis 
of implant survivorship for 
aseptic loosening for aug-
mentable and non-augmentable 
implant cohorts (p = 0.024). All 
other revisions were censored at 
their revision dates and included 
in this analysis


































Table 3  Assessment of cementation and alignment for a control 
group of augmentable knees which did not loosen (n = 20), a con-
trol group of non-augmentable knees which did not loosen (n = 20), 
non-augmentable knees which required revision for aseptic loosening 
(n = 20) and augmentable knees which required revision for aseptic 
loosening (n = 2)
Statistical analysis presented compares control groups to non-augmentable aseptic loosening group where *p < 0.05, **p < 0.01 and ***p < 0.001
Statistical analysis was not performed on the augmentable aseptic loosening group due to the low number of patients










  Age 66.5 (7.2) 66.5 (7.5) 66.3 (7.1) 55.5 (0.5)
  Female 9 10 10 1
  BMI 32.2 (4.6) 32.4 (5) 32.4 (5) 40.5 (6.4)
Component alignment ( ◦)
  Femoral component valgus 6.1 (1.8) 5.4 (2.1) 6.2 (2.4) 1.5 (0.7)
  Tibial component varus 2.1 (1.8) 1.5 (1.5) 2.6 (1.6) 4 (0)
  Tibial component sagittal slope 3.4 (3.2)* 3.2 (3.4)* 5.6 (2.6) 6.5 (3.5)
Measures of cement mantle
  No. of zones cement penetration < 2 mm 1.1 (1.1) 1.7 (1) 2 (1.4) 3.5 (3.5)
  No. of RLL at implant cement interface 0.3 (0.8)*** 0.8 (0.9)* 1.9 (1.2) 4 (4.2)
  No. of RLL at cement–bone interface 0.6 (0.6) 0.7 (0.8) 1.2 (1) 2.5 (0.7)
  % surface area RLL compared to surface 
area available




The purpose of this study was to ascertain differences in 
rates of aseptic loosening between augmentable and non-
augmentable NexGen TKA tibial baseplates used in our unit. 
We confirmed our hypothesis of increased rates of aseptic 
loosening in non-augmentable components at five years 
(p = 0.0241) although it may not be possible to confirm 
that this was solely as a consequence of changes to implant 
design. There was no significant difference between the 
cohorts in terms of age or BMI which could account for 
this difference. We did observe some subtle differences in 
relation to the quality of the cement mantle in the non-aug-
mentable knees which went on to aseptic loosening. The 
link between cement mantle quality and risk of aseptic loos-
ening has already been shown [8]. In particular, we noted 
the consistent appearance of a RLL at the tip of the stem, 
at the implant cement interface of the non-augmentable 
components (Fig. 6). In the cases which went on to aseptic 
loosening, this line seems to progress and failure occurs at 
the implant cement interface. We observed less posterior 
slope in the knees which did not require revision compar-
ing to those that went on to loosen aseptically. This was an 
unexpected finding. We exclusively use the 7° baseplates 
within our unit because increased posterior slope has been 
shown to increase post-operative range of flexion [9]. Our 
intra-operative cutting procedure is in keeping with the 
operative technique guidance from Zimmer Biomet using 
an extramedullary jig to match the native tibial alignment 
and a cutting block to build in the required 7° of posterior 
slope. It has previously been established that excessive slope 
leads to flexion instability and even early failure through 
detensioning of the collateral ligaments [10, 11]. This may 
offer some explanation for our findings but the overall num-
bers in the alignment comparison are small so we are reluc-
tant to make any unjustified conclusions in this regard. The 
increased rates of RLL in the knees which went on to fail 
suggest that cementation technique may have played a role 
in the differences observed between our two groups. The 
effect of the PMMA pre-coating is also difficult to establish 
definitively. A previous study demonstrated lower rates of 
aseptic loosening in NexGen tibial baseplates which were 
non-pre-coated [12]. Conversely, a recent study raised con-
cerns regarding rates of aseptic loosening in non-pre-coated 
baseplates although there was no direct comparison drawn 
with the pre-coated version [6]. In that context, it is dif-
ficult for us to ascertain the exact effect that the PMMA 
pre-coating had in our study but we can conclude that it 
may have contributed to the differences observed between 
our two groups.
There are several theories on the causes of aseptic loosen-
ing. As early as 1976, Harris noted loosening without infec-
tion in 4 hip arthroplasties [13]. His initial particle disease 
theory, which resulted in the development of uncemented 
implants [14, 15], did not have a positive effect on rates of 
aseptic loosening, which suggested that the mechanism is 
likely to be multifactorial. The effective joint space theory 
was first described in 1992 when it was hypothesised that 
polyethylene wear particles are dispersed into the effec-
tive joint space or that cement particles are generated by 
debonding or cement fracture [16]. According to this the-
ory, access to the effective joint space is influenced by the 
cement/implant and cement/bone interfaces. Wear particles 
activate macrophages which release cytokines involved in 
bone remodelling such as prostaglandin E2, interleukin 1α, 
interleukin 6 and tumour necrosis factor α. These cytokines 
modulate osteoclast and osteoblast activity which results in 
osteolysis and an increase in the effective joint space [14, 
17]. Macrophages may also differentiate into osteoclasts 
directly to further resorb bone tissue [18]. Stress shielding 
may also occur in the proximal tibia following total knee 
arthroplasty. The resultant osteopenia in the bone of the 
proximal tibia can allow micromotion of the implant which 
has been shown to result in failure [17]. There is also vari-
ation between individuals in the observed rates of osteoly-
sis and it has been proposed that this may be secondary to 
an adverse cellular response [19]. Exactly, which factors 
predispose to aseptic loosening is still a matter of debate. 
Some authors have found an association with post-operative 
varus malalignment of the tibial component and increased 
BMI [20, 21]. Others have suggested that aseptic loosening 
occurs as a direct result of poor cement mantle quality [8]. 
With cementation being a key factor, some authors suggest 
that technical factors have the most influence over aseptic 
Fig. 6  An immediate post-operative lateral radiograph of a non-aug-
mentable TKA. As visible here, we noted the consistent presence of 
a radiolucent line at the implant/cement interface at the tip of the keel
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loosening rates [4]. But a systematic review was only able to 
relate an increased risk of aseptic loosening to male gender 
and high activity levels [22]. There have certainly been high 
rates of aseptic loosening observed with specific components 
which has led to a decrease in their usage [23].
Interpretation of our results in comparison to the litera-
ture is challenging. As previously noted, a number of dif-
ferent versions of the NexGen tibial baseplate are available, 
and in some studies, it can be difficult to determine exactly 
which version was being used [24, 25]. Similar problems are 
encountered when assessing arthroplasty registry data, and 
the cause of revision is often not clear [2]. Joint registry data 
for England and Wales has shown an all cause revision rate 
for the NexGen implant of 2.17% at five years [2]. This com-
pares to our all cause revision rate of 2.85% at the same time 
point. The all cause revision rate for the non-augmentable 
tibial baseplate in our study however was 3.4% compared to 
a 1.84% rate in the augmentable group. This difference was 
not statistically significant (p = 0.0562). When we consider 
the rates of revision for aseptic loosening, it is useful to draw 
comparison to the results obtained by Arsoy et al. in 2013 
[5]. In this study with similar methodology to our study, 
they observed a 2.2% revision rate for aseptic loosening at 
five years when assessing the 3° augmentable NexGen tibial 
baseplate. Our results compare favourably with these find-
ings given that we found a revision rate for aseptic loosen-
ing of 0.26% at five years for the 7° augmentable baseplate 
and 1.42% for the non-augmentable 7° baseplate. Whilst our 
rates of revision for aseptic loosening in both groups com-
pare favourably with previously reported rates, we have dem-
onstrated an increased rate of revision for aseptic loosening 
at five years in the non-augmentable baseplate compared to 
the augmentable alternative. We have been unable to explain 
the difference observed when considering BMI or age but we 
accept that cementation technique may have played a role.
The strengths of this study include the overall patient 
numbers and the methodology. We also use the NexGen 
exclusively within our unit which ensures that all surgeons 
are familiar with it and there are no low-volume surgeons 
involved in this study in either time period.
There are a number of weaknesses in the study. When 
assessing alignment of the non-augmentable knees which 
failed due to aseptic loosening, we used short knee radio-
graphs. Clearly, the use of long-leg alignment films would 
have been preferable but these were rarely available and the 
use of the short knee radiograph has been validated in previ-
ous studies [8]. BMI data was incomplete in our database 
but was present in similar proportions for both cohorts. We 
recognise that using revision as an endpoint for failure has 
its shortcomings and is likely to overestimate implant suc-
cess. Furthermore, there is a small chance that there were 
some failures who underwent revision out with our local 
area or in the private sector. Evidence from the Scottish 
Arthroplasty Project in 2009 showed that the overall num-
bers of patients moving between health boards were small 
around the time of our study [26]. Furthermore, patients 
who undergo revision within Scotland are traced back to 
the hospital in which they underwent primary surgery when 
their data is collected for the Scottish Arthroplasty Project. 
Only patients who underwent revision surgery out with Scot-
land or within the private sector would have been missed in 
a national Picture Archiving and Communication System 
(PACS) search. Refobacin® cement (Zimmer Biomet, War-
saw, IN, USA) was only used in the non-augmentable cohort 
given the timing of the introduction of this product in our 
institution. It is possible therefore that this could have con-
tributed to the aseptic loosening rate differences or indeed 
the radiographic differences within the cement mantle. In 
2011 though, we were using non-augmentable baseplates 
with the original Palacos® R&G (Heraeus Medical, Hanau, 
Germany) cement. In that year, we found that there were 5 
knees which went onto aseptic loosening. The rate of failure 
of the non-augmentable baseplate did not increase further 
after the cement was changed although because the overall 
numbers per year were very small, statistical analysis has 
not been performed. Previous evidence from the Norwegian 
arthroplasty register has shown similar survival of TKAs 
cemented with Palacos versus those cemented with Refo-
bacin [27].
To our knowledge, ours is the first study to compare 
aseptic loosening rates between these two baseplate types 
although a recent paper compared rates of aseptic loosening 
between the NexGen non-modular baseplate and Sigma® 
P.F.C® TKA (DePuy Synthes, Warsaw, Indiana) and found 
much higher rates of aseptic loosening of the NexGen tibial 
baseplate [24]. Whilst our rates of aseptic loosening from 
both implants are likely to be within what might be consid-
ered acceptable limits, the difference observed highlights 
the effect that minor changes to an implant can have on out-
comes in the medium term. With a great deal of heteroge-
neity within arthroplasty registry data, it is important that 
clinicians remain alert to seemingly minor implant changes 
within their own units and publish their own results when 
important trends are observed. Our regional Zimmer Biomet 
representative has confirmed that in the last ten  years, 
78.84% of all primary NexGen knees implanted in the UK 
were non-augmentable.
In conclusion, we have demonstrated a significantly 
higher rate of aseptic loosening in the Zimmer NexGen TKA 
when using a non-augmentable 7° baseplate compared to 
an augmentable 7° baseplate. Further investigation of the 
rates of aseptic loosening in the non-augmentable base-
plate at other units may be warranted to determine if these 
findings are replicable or if they may in part be due to the 
introduction of Refobacin® cement. Given the lower cost 
of the non-augmentable baseplate, a cost analysis based on 
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the increased rate of revision observed may also be useful 
in order to consider whether there is any financial benefit in 
using this implant.
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